CS-17919

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCS-17919
Drug Alias NameCS17919
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis signal-regulating kinase 1 inhibitors
TargetsApoptosis signal-regulating kinase 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2Renal Insufficiency, ChronicMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen Chipscreen Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Chipscreen Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Renal Insufficiency, ChronicMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A